Citations

Showing 10 of 108119 citations.

Trifocal Tibial Bone Transport Using a Magnetic Intramedullary Nail
Hwang, James , Sems, S.A. , Yuan, Brandon J. , Sems, Stephen A , Yuan, Brandon

Mayo Clinic

JBJS Case Connector | October 29, 2021 | Volume: 11 | Issue: 4 | Pages: No page available

10.2106/jbjs.cc.20.01036 | PMID 34714809 Get It

Case: The patient sustained a pathologic fracture through chronic osteomyelitis of the tibia. Treatment involved resection of bone and soft tissue, leaving a 15-cm diaphyseal tibial defect. We designed a construct to allow for trifocal bone transport using a magnetic intramedullary lengthening nail connected to cables. This technique uses cables secured to the proximal tibia, the nail, and the transport segments. Conclusion: This case details the successful use of trifocal cable-assisted bone transport through a magnetic lengthening intramedullary nail. This technique can successfully be used to reconstruct diaphyseal bone defects that are longer than the stroke length of the magnetic nail.
Focused Versus Conventional Radiotherapy in Spinal Oncology: Is There any Difference in Fusion Rates and Pseudoarthrosis?
Akinduro, Oluwaseun O. , DeBiase, Geatano, Meyer, Jenna H., Sheehan, Jason P. , Merrell, Kenneth W. , Vora, Sujay A., Broderick, Daniel F. , Clarke, Bydon, Mohamad , McClendon, Jamal, Kalani, Maziyar A. , Quiñones‐Hinojosa, Alfredo , Goyal, Anshit , Kowalchuk, Roman O. , Sandhu, Sukhwinder J.S. , Trifiletti, Daniel M. , Abode-Iyamah, Kingsley

Mayo Clinic

No container title available | October 29, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-973693/v1 Get It

Abstract IntroductionRadiotherapy is considered standard of care for adjuvant peri-operative treatment of many spinal tumors, including those with instrumented fusion. Unfortunately, radiation treatment has been linked to increased risk of pseudoarthrosis. Newerfocused radiotherapy strategies with enhanced conformalitycould offer improved fusion rates for these patients, but this has not been confirmed.MethodsWe performed a retrospective analysis of patients at three tertiary care academic institutions withprimary and secondary spinal malignancies that underwent resection, instrumented fusion, and peri-operative radiotherapy. Two board certified neuro-radiologists used theLenke fusion score to grade fusion status at6 and 12-months after surgery. Secondary outcomes includedclinical pseudoarthrosis, wound complications, and the effect of radiation timing, radiobiological dose delivered, the use of photons versus protons, tumor type, tumor location,and use of autograft on fusion outcomes.ResultsAfter reviewof 1252 spinal tumor patients, there were 60 patients with at least 6 months follow-up that were included in our analyses. Twenty-five of these patients received focused radiotherapy,20 patients received conventional radiotherapy, and 15 patients were treated with protons. There was no significant difference between the groups for covariates such assmoking status,obesity, diabetes, intraoperative use of autograft, and use of peri-operative chemotherapy. There was a significantly higher rate of fusion for patients treated with focused radiotherapy compared to those treated with conventional radiotherapy at 6-months (64.0% versus 30.0%, Odds ratio: 4.15, p=0.036) and 12-months (80.0% versus 42.1%, OR: 5.50, p=0.022). There was a significantly higher rate of clinical pseudoarthrosis in the conventional radiotherapy cohortcompared to patients in the focused radiotherapy cohort (19.1% versus 0%,p=0.037). There was no difference in fusion outcomes for any of the secondary outcomes except for use of autograft. The use ofintra-operative autograft was associated with an improved fusion at 12-months (66.7% versus 37.5%, OR: 3.33, p=0.043). ConclusionFocused radiotherapy may be associated withan improved rate of fusion and clinical pseudoarthrosis when compared to conventional radiation delivery strategiesin patients with spinal tumors.Use of autograft at the time of surgery may be associated with improved 12-month fusion rates.Further large-scale prospective and randomized controlled studies are needed to better stratify the effects of radiation delivery modality in these patients.
Alcohol‐Related Liver Disease
Robinson, Kyle E. , Shah, Vijay H. , Robinson, Kyle

Mayo Clinic

Clinical Liver Disease | October 29, 2021 | Volume: 18 | Issue: S1 | Pages: 93-106

10.1002/cld.1162 | PMID 34745586 Get It

A History of the Assessment of Liver Performance
Mousa, Omar Y. , Kamath, Patrick S.

Mayo Clinic

Clinical Liver Disease | October 29, 2021 | Volume: 18 | Issue: S1 | Pages: 28-48

10.1002/cld.1100 | PMID 34745582 Get It

Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease
Stan, Marius N. , Murthy, Vishakantha , Thapa, Prabin , Araki, Naohiro, Stan, Marius N , Algeciras‐Schimnich, Alicia

Mayo Clinic

Thyroid® | October 29, 2021 | Volume: 32 | Issue: 2 | Pages: 170-176

10.1089/thy.2021.0299 | PMID 34714163 Get It

Background: The syndrome of thyrotoxicosis typically relies on radioactive iodine scans for establishing its etiology. Alternatively, the determination of thyrotropin (TSH) receptor antibodies (TRAbs) helps to distinguish Graves' disease (GD) from thyrotoxic thyroiditis. Current assays are impacted by limitations in sensitivity and/or turnaround time. Therefore, we decided to test a new assay for the detection of TSH receptor stimulating antibodies (TSAbs) and compare it with the clinically available assays. Methods: We enrolled 110 individuals in 5 cohorts: patients with incident or recurrent GD (cohort 1); patients with thyroiditis, painless or subacute (cohort 2); patients with Graves' orbitopathy/thyroid eye disease (TED) in cohort 3; patients with Hashimoto's thyroiditis (cohort 4), and a control group of normal volunteers (cohort 5). The patients were tested with the two clinically available assays: Roche Elecsys anti-TSHR assay (ROC-TBII) from Roche Diagnostics and Thyretain™ TSI Reporter BioAssay Kit (QUI-TSI) from Quidel. In addition, the samples were tested with the aequorin TSAb assay (OTS-TSI) provided by Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan). The data were collected in a cross-sectional manner before initiation of therapy. Results: We had 36 cases of GD, 17 cases of thyroiditis, 27 cases of TED, 10 cases of Hashimoto's thyroiditis, and 20 normal volunteers. OTS-TSI had 100% sensitivity and specificity in distinguishing GD from thyroiditis, identical with QUI-TSI but superior to ROC-TBII (sensitivity 86% and specificity 94.1%). OTS-TSI had 93% sensitivity and 100% specificity for the diagnosis of TED, compared with normal controls. QUI-TSI and ROC-TBII performed similarly in this analysis, demonstrating 82% sensitivity and 100% specificity. The range of detectable values for OTS-TSI was 20–29,000 mIU/L and the turnaround time was ≤6 hours, without the need for cell culture equipment. Conclusions: OTS-TSI performed excellently, though similarly to QUI-TSI, for the differential diagnosis of GD vs. thyroiditis, while being superior in that respect to ROC-TBII. Furthermore, OTS-TSI has superior sensitivity to QUI-TSI and ROC-TBII for TED diagnosis, while retaining high specificity. It has a short turnaround time and avoids the need for cell culture and sterility. Larger studies in U.S. populations are needed for its validation.
“We Are from Nowhere”: A Qualitative Assessment of the Impact of Collective Trauma from the Perspective of Resettled Bhutanese Refugees
Salinas, Manisha , Salinas, Juan L. , Salinas, Juan L.

Mayo Clinic

Health Equity | October 29, 2021 | Volume: 5 | Issue: 1 | Pages: 762-769

10.1089/heq.2020.0116 | PMID 34909546 Get It

Women and Men National Collegiate Athletic Association Ice Hockey Players Were Similarly Likely to Suffer Lumbar Spine Injuries
Jenkins, Anna , Brinkman, Joseph C. , Kropelnicki, Merritt C., Makovicka, Justin L. , Hassebrock, Jeffrey D. , Jenkins, Anna S, Hassebrock, Jeffrey D , Jenkins, Anna S , Tummala, Sailesh V , Pollock, Jordan Riley , Tummala, Sailesh V. , Chhabra, Anikar

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | October 29, 2021 | Volume: 3 | Issue: 6 | Pages: No page available

10.1016/j.asmr.2021.09.016 | PMID 34977652 Get It

Purpose To describe and compare the epidemiology of lumbar spine injuries (LSIs) in women’s and men’s ice hockey during the 2009‐2010 to 2013‐2014 academic years and to investigate sex‐specific differences, using data from the National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) database. Methods The incidence and characteristics of LSIs were identified utilizing the NCAA ISP. Rates of injury were calculated as number of injuries divided by total number of athlete exposures (AEs). AEs were defined as any student participation in one NCAA‐sanctioned practice or competition. Incidence rate ratios (IRRs) were calculated to compare rates of injury between season, event type, mechanism, injury recurrence, and time lost from sport, and injury proportion ratios (IPRs) were calculated to examine the differences in injury rates between men and women. Results There were a total of 165 LSIs from an average of 10 and 19 women’s and men’s teams, respectively, calculated to 1,254 LSIs nationally. Women were 2.48 times more likely to suffer a noncontact injury than men (95% CI: 1.33‐4.61), whereas men were more likely than women to suffer contact LSIs (IPR: .51 [95% CI: .28‐.92]). In Divisions II and III, women were 6.64 (95% CI: 4.14‐10.64) and 1.28 (95% CI: 1.12‐1.46) times more likely to suffer LSIs than men, respectively. Conclusions Women and men were similarly likely to suffer an LSI, but sex‐specific differences existed in a mechanism of injury and likelihood of injury within NCAA Divisions.
Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock
Jung, Richard G. , Santo, Pietro Di, Mathew, Rebecca, Abdel‐Razek, Omar, Parlow, Simon , Simard, Trevor, Marbach, Jeffrey A., Gillmore, Taylor, Mao, Brennan, Bernick, Jordan, Theriault‐Lauzier, Pascal , Fu, Angel, Lau, Lawrence, Motazedian, Pouya, Russo, Juan J., Labinaz, Marino, Hibbert, Benjamin , Hibbert, Benjamin , Jung, Richard G. , Santo, Pietro Di, Mathew, Rebecca, Abdel‐Razek, Omar, Parlow, Simon , Simard, Trevor, Marbach, Jeffrey A., Gillmore, Taylor, Mao, Brennan, Bernick, Jordan, Theriault‐Lauzier, Pascal , Fu, Angel, Lau, Lawrence, Motazedian, Pouya, Russo, Juan J., Labinaz, Marino

Mayo Clinic

Journal of the American Heart Association | October 29, 2021 | Volume: 10 | Issue: 21 | Pages: No page available

10.1161/jaha.121.021570 | PMID 34713704 Get It

Background The randomized DOREMI (Dobutamine Compared to Milrinone) clinical trial evaluated the efficacy and safety of milrinone and dobutamine in patients with cardiogenic shock. Whether the results remain consistent when stratified by acute myocardial infarction remains unknown. In this substudy, we sought to evaluate differences in clinical management and outcomes of acute myocardial infarction complicated by cardiogenic shock (AMICS) versus non‐AMICS. Methods and Results Patients in cardiogenic shock (n=192) were randomized 1:1 to dobutamine or milrinone. The primary composite end point in this subgroup analysis was all‐cause in‐hospital mortality, cardiac arrest, non‐fatal myocardial infarction, cerebrovascular accident, the need for mechanical circulatory support, or initiation of renal replacement therapy (RRT) at 30‐days. Outcomes were evaluated in patients with (n=65) and without (n=127) AMICS. The primary composite end point was significantly higher in AMICS versus non‐AMICS (hazard ratio [HR], 2.21; 95% CI, 1.47–3.30; P =0.0001). The primary end point was driven by increased rates of all‐cause mortality, mechanical circulatory support, and RRT. No differences in other secondary outcomes including cardiac arrest or cerebrovascular accident were observed. AMICS remained associated with the primary composite outcome, 30‐day mortality, and RRT after adjustment for age, sex, procedural contrast use, multivessel disease, and inotrope type. Conclusions AMI was associated with increased rates of adverse clinical outcomes in cardiogenic shock along with increased rates of mortality and initiation of mechanical circulatory support and RRT. Contrast administration during revascularization likely contributes to increased rates of RRT. Heterogeneity of outcomes in AMICS versus non‐AMICS highlights the need to study interventions in specific subgroups of cardiogenic shock. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03207165.
Modulation of dopamine release by ethanol is mediated by atypical GABAA receptors on cholinergic interneurons in the nucleus accumbens
Wadsworth, Hillary A. , Williams, Benjamin M. , Brundage, James , Hedges, David M. , Stockard, Alyssa , Jones, Stephen T., Arthur, Summer B., Hansen, David M., Schilaty, Nathan D. , Jang, Eun Young , Lee, Anna , Wallner, Martin , Yorgason, Jordan T , Lee, Anna M , Steffensen, Scott C , Stockard, Alyssa , Schilaty, Nathan D , Yorgason, Jordan T. , Anderson, Elizabeth J., Jones, Stephen T., Steffensen, Scott C.

Mayo Clinic

Addiction Biology | October 29, 2021 | Volume: 27 | Issue: 1 | Pages: No page available

10.1111/adb.13108 | PMID 34713509 Get It

AbstractPrevious studies indicate that moderate‐to‐high ethanol (EtOH) concentrations enhance dopamine (DA) neurotransmission in the mesolimbic DA system from the ventral tegmental area (VTA) and projecting to the nucleus accumbens core (NAc). However, voltammetry studies demonstrate that moderate‐to‐high EtOH concentrations decrease evoked DA release at NAc terminals. The involvement of γ‐aminobutyric acid (GABA) receptors (GABAARs), glycine (GLY) receptors (GLYRs) and cholinergic interneurons (CINs) in mediating EtOH inhibition of evoked NAc DA release were examined. Fast scan cyclic voltammetry, electrophysiology, optogenetics and immunohistochemistry techniques were used to evaluate the effects of acute and chronic EtOH exposure on DA release and CIN activity in C57/BL6, CD‐1, transgenic mice and δ‐subunit knockout (KO) mice (δ−/−). Ethanol decreased DA release in mice with an IC50 of 80 mM ex vivo and 2.0 g/kg in vivo. GABA and GLY decreased evoked DA release at 1–10 mM. Typical GABAAR agonists inhibited DA release at high concentrations. Typical GABAAR antagonists had minimal effects on EtOH inhibition of evoked DA release. However, EtOH inhibition of DA release was blocked by the α4β3δ GABAAR antagonist Ro15‐4513, the GLYR antagonist strychnine and by the GABA ρ1 (Rho‐1) antagonist TPMPA (10 μM) and reduced significantly in GABAAR δ−/− mice. Rho‐1 expression was observed in CINs. Ethanol inhibited GABAergic synaptic input to CINs from the VTA and enhanced firing rate, both of which were blocked by TPMPA. Results herein suggest that EtOH inhibition of DA release in the NAc is modulated by GLYRs and atypical GABAARs on CINs containing δ‐ and Rho‐subunits.
Perineural spread of peripheral neurolymphomatosis to the cauda equina
Murthy, Nikhil K. , Amrami, Kimberly K. , Johnston, Patrick B. , Spinner, Robert J. , Broski, Stephen M.

Mayo Clinic

Journal of Neurosurgery: Spine | October 29, 2021 | Volume: 36 | Issue: 3 | Pages: 464-469

10.3171/2021.4.spine21344 | PMID 34598154 Get It

OBJECTIVE Neurolymphomatosis (NL) is a rare manifestation of lymphoma confined to the peripheral nervous system that is poorly understood. It can be found in the cauda equina, but extraspinal disease can be underappreciated. The authors describe how extraspinal NL progresses to the cauda equina by perineural spread and the implications of this on timely and safe diagnostic options. METHODS The authors used the Mayo Clinic medical records database to find cases of cauda equina NL with sufficient imaging to characterize the lumbosacral plexus diagnosed from tissue biopsy. Demographics (sex, age), clinical data (initial symptoms, cerebrospinal fluid, evidence of CNS involvement, biopsy location, primary or secondary disease), and imaging findings were reviewed. RESULTS Ten patients met inclusion and exclusion criteria, and only 2 of 10 patients presented with cauda equina symptoms at the time of biopsy, with 1 patient undergoing a cauda equina biopsy. Eight patients were diagnosed with diffuse large B-cell lymphoma, 1 with low-grade B-cell lymphoma, and 1 with mantle cell lymphoma. Isolated spinal nerve involvement was identified in 5 of 10 cases, providing compelling evidence regarding the pathophysiology of NL. The conus medullaris was not radiologically involved in any case. Lumbosacral plexus MRI was able to identify extraspinal disease and offered diagnostically useful biopsy targets. FDG PET/CT was relatively insensitive for detecting disease in the cauda equina but was helpful in identifying extraspinal NL. CONCLUSIONS The authors propose that perineural spread of extraspinal NL to infiltrate the cauda equina occurs in two phases. 1) There is proximal and distal spread along a peripheral nerve, with eventual spread to anatomically connected nerves via junction and branch points. 2) The tumor cells enter the spinal canal through corresponding neural foramina and propagate along the spinal nerves composing the cauda equina. To diffusely infiltrate the cauda equina, a third phase occurs in which tumor cells can spread circumdurally to the opposite side of the spinal canal and enter contralateral nerve roots extending proximally and distally. This spread of disease can lead to diffuse bilateral spinal nerve disease without diffuse leptomeningeal spread. Recognition of this phasic mechanism can lead to identification of safer extraspinal biopsy targets that could allow for greater functional recovery after appropriate treatment.